Resolvin d1

Resolvin d1 is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 305 references associated with Resolvin d1 in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Resolvin d1

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Resolvin d1

PubChem Biomolecular Interactions and Pathways

All references with Resolvin d1

Download all related citations
Per page 10 20 50 100 | Total 185
Authors Title Published Journal PubMed Link
pmid:26718448
pmid:25908532
pmid:25890752
pmid:24929111
pmid:27573422
pmid:26638987
pmid:26630551
pmid:29095817
pmid:27559094
pmid:26597784
pmid:27508346
pmid:25806690
pmid:24784707
pmid:28779028
pmid:26550951
pmid:28694292
pmid:28610917
pmid:28584076
pmid:26531230
pmid:27362771
pmid:26492476
pmid:28442547
pmid:27317426
pmid:24571866
pmid:24451959
pmid:28322829
pmid:26335632
pmid:28237084
pmid:28218420
pmid:25453942
pmid:27044027
pmid:22610993
pmid:27034112
pmid:26927755
pmid:26159746
pmid:25218162
pmid:26118631
pmid:25123641
pmid:26808633
pmid:27133431
pmid:25030943
pmid:
Wang X et al. Resolution of inflammation is altered in Alzheimer's disease. 2015 Alzheimers Dement pmid:24530025
Hsiao HM et al. Resolvin D1 Reduces Emphysema and Chronic Inflammation. 2015 Am. J. Pathol. pmid:26468975
Krishnamoorthy S et al. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. 2012 Am. J. Pathol. pmid:22449948
Liu Y et al. Resolvin D1 protects against inflammation in experimental acute pancreatitis and associated lung injury. 2016 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:26702138
Hiram R et al. Resolvin D1 reverses reactivity and Ca2+ sensitivity induced by ET-1, TNF-α, and IL-6 in the human pulmonary artery. 2014 Am. J. Physiol. Heart Circ. Physiol. pmid:25281570
Croasdell A et al. Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages. 2015 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:26301452
Orr SK et al. Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent. 2015 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:25770181
Hiram R et al. Resolvin E1 normalizes contractility, Ca2+ sensitivity and smooth muscle cell migration rate in TNF-α- and IL-6-pretreated human pulmonary arteries. 2015 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:26320154
Shinohara M et al. Cell-cell interactions and bronchoconstrictor eicosanoid reduction with inhaled carbon monoxide and resolvin D1. 2014 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:25217660
Mustafa M et al. Resolvin D1 protects periodontal ligament. 2013 Am. J. Physiol., Cell Physiol. pmid:23864609
Odusanwo O et al. Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation. 2012 Am. J. Physiol., Cell Physiol. pmid:22237406
Nelson JW et al. ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands. 2014 Am. J. Physiol., Cell Physiol. pmid:24259417
Cox R et al. Enhanced Resolution of Hyperoxic Acute Lung Injury as a result of Aspirin Triggered Resolvin D1 Treatment. 2015 Am. J. Respir. Cell Mol. Biol. pmid:25647402
Wendel M and Heller AR Anticancer actions of omega-3 fatty acids--current state and future perspectives. 2009 Anticancer Agents Med Chem pmid:19442044
Norling LV et al. Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:22499990
Prieto P et al. Activation of autophagy in macrophages by pro-resolving lipid mediators. 2015 Autophagy pmid:26506892
Fredman G and Serhan CN Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. 2011 Biochem. J. pmid:21711247
Lee HN and Surh YJ Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis. 2013 Biochem. Pharmacol. pmid:23856291
de Oliveira JR et al. AT-RvD1 modulates CCL-2 and CXCL-8 production and NF-κB, STAT-6, SOCS1, and SOCS3 expression on bronchial epithelial cells stimulated with IL-4. 2015 Biomed Res Int pmid:26075216
Lim JY et al. Biological Roles of Resolvins and Related Substances in the Resolution of Pain. 2015 Biomed Res Int pmid:26339646
Dalli J and Serhan CN Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. 2012 Blood pmid:22904297
Quan-Xin F et al. Resolvin D1 reverses chronic pancreatitis-induced mechanical allodynia, phosphorylation of NMDA receptors, and cytokines expression in the thoracic spinal dorsal horn. 2012 BMC Gastroenterol pmid:23092159
Spite M et al. Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress. 2009 Br. J. Pharmacol. pmid:19422383
Bang S et al. 17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception. 2012 Br. J. Pharmacol. pmid:21718307
Bang S et al. Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. 2010 Br. J. Pharmacol. pmid:20880407
Lima-Garcia JF et al. The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats. 2011 Br. J. Pharmacol. pmid:21418187
Filep JG Lipid mediator interplay: resolvin D1 attenuates inflammation evoked by glutathione-conjugated lipid peroxidation products. 2009 Br. J. Pharmacol. pmid:19845687
Harrison JL et al. Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse. 2015 Brain Behav. Immun. pmid:25585137
Zhao YL et al. Resolvin D1 Protects Lipopolysaccharide-induced Acute Kidney Injury by Down-regulating Nuclear Factor-kappa B Signal and Inhibiting Apoptosis. 2016 Chin. Med. J. pmid:27098797
Mas E et al. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. 2012 Clin. Chem. pmid:22912397
Xu MX et al. Resolvin D1, an endogenous lipid mediator for inactivation of inflammation-related signaling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses. 2013 CNS Neurosci Ther pmid:23521911
Tang Y et al. Proresolution therapy for the treatment of delayed healing of diabetic wounds. 2013 Diabetes pmid:23043160
Koltsida O et al. Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation. 2013 EMBO Mol Med pmid:23584892
Chen F et al. Resolvin D1 improves survival in experimental sepsis through reducing bacterial load and preventing excessive activation of inflammatory response. 2014 Eur. J. Clin. Microbiol. Infect. Dis. pmid:24072678
Kim N et al. Specialized proresolving mediators (SPMs) inhibit human B-cell IgE production. 2016 Eur. J. Immunol. pmid:26474728
Schif-Zuck S et al. Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. 2011 Eur. J. Immunol. pmid:21268007
Haworth O and Levy BD Endogenous lipid mediators in the resolution of airway inflammation. 2007 Eur. Respir. J. pmid:17978156
Kaarniranta K and Salminen A NF-kappaB signaling as a putative target for omega-3 metabolites in the prevention of age-related macular degeneration (AMD). 2009 Exp. Gerontol. pmid:19751815
Lehmann C et al. Lipoxin and resolvin biosynthesis is dependent on 5-lipoxygenase activating protein. 2015 FASEB J. pmid:26289316
Fiala M et al. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. 2015 FASEB J. pmid:25805829
Dalli J et al. Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways. 2015 FASEB J. pmid:25713027
Lastrucci C et al. Molecular and cellular profiles of the resolution phase in a damage-associated molecular pattern (DAMP)-mediated peritonitis model and revelation of leukocyte persistence in peritoneal tissues. 2015 FASEB J. pmid:25609430
Kurihara T et al. Resolvin D2 restores neutrophil directionality and improves survival after burns. 2013 FASEB J. pmid:23430978
Miyahara T et al. D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury. 2013 FASEB J. pmid:23407709
Hellmann J et al. Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. 2011 FASEB J. pmid:21478260
Terrando N et al. Aspirin-triggered resolvin D1 prevents surgery-induced cognitive decline. 2013 FASEB J. pmid:23709617
Recchiuti A et al. Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. 2014 FASEB J. pmid:24692596
Recchiuti A et al. MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. 2011 FASEB J. pmid:20956612
Merched AJ et al. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. 2008 FASEB J. pmid:18559988
Rius B et al. Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis. 2014 FASEB J. pmid:24249635
Chung ML et al. Profiling of oxidized lipid products of marine fish under acute oxidative stress. 2013 Food Chem. Toxicol. pmid:23220612
Weylandt KH et al. Lipoxins and resolvins in inflammatory bowel disease. 2007 Inflamm. Bowel Dis. pmid:17262807
Benabdoune H et al. The role of resolvin D1 in the regulation of inflammatory and catabolic mediators in osteoarthritis. 2016 Inflamm. Res. pmid:27056390
Zhao Q et al. Resolvin D1 Alleviates the Lung Ischemia Reperfusion Injury via Complement, Immunoglobulin, TLR4, and Inflammatory Factors in Rats. 2016 Inflammation pmid:27145782
Gu Z et al. Resolvin D1, resolvin D2 and maresin 1 activate the GSK3β anti-inflammatory axis in TLR4-engaged human monocytes. 2016 Innate Immun pmid:26878867
Kim KH et al. Resolvin D1 prevents smoking-induced emphysema and promotes lung tissue regeneration. 2016 Int J Chron Obstruct Pulmon Dis pmid:27313451
Lee HJ et al. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32. 2013 Int. J. Biochem. Cell Biol. pmid:24120851
Jin Y et al. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. 2009 Invest. Ophthalmol. Vis. Sci. pmid:19407006

Table of Content